Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11484590 Human cytomegalovirus RNA vaccines

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 27, 2020
Date of Patent
November 1, 2022
Patent Application Number
16833409
Patent Citations
‌
US Patent 10273269 High potency immunogenic zika virus compositions
‌
US Patent 10022435 Nucleic acid vaccines
‌
US Patent 10064934 Combination PIV3/hMPV RNA vaccines
‌
US Patent 10064935 Human cytomegalovirus RNA vaccines
‌
US Patent 10124055 Zika virus RNA vaccines
‌
US Patent 10207010 Compositions and methods for delivery of agents
‌
US Patent 10232055 RNA containing modified nucleosides and methods of use thereof
‌
US Patent 10286086 Alternative nucleic acid molecules and uses thereof
‌
US Patent 10323076 Polynucleotides encoding low density lipoprotein receptor
‌
US Patent 10385088 Polynucleotide molecules and uses thereof
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11484590
Patent Primary Examiner
‌
Rachel B Gill
CPC Code
‌
A61K 31/7115
‌
A61K 39/12
‌
A61K 39/39
‌
A61K 2039/53
‌
A61K 2039/55
‌
A61K 2039/55511
‌
A61K 2039/55555
‌
A61K 2039/55566
‌
A61K 2039/575
‌
C07K 14/005
•••

Find more entities like US Patent 11484590 Human cytomegalovirus RNA vaccines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.